Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opioids and their receptors: Are we there yet?
Gavril W. Pasternak
Neuropharmacology (2013) Vol. 76, pp. 198-203
Open Access | Times Cited: 106

Showing 26-50 of 106 citing articles:

Mechanism and effects of STING–IFN-I pathway on nociception: A narrative review
Jinghan Yang, Hui Ding, Bo Shuai, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 15
Open Access | Times Cited: 9
An Introduction to Pain Pathways and Pain “Targets”
Vaskar Das
Progress in molecular biology and translational science (2015), pp. 1-30
Closed Access | Times Cited: 32
Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist – Neurokinin-1 antagonist peptidomimetics
Karel Guillemyn, Patrycja Kleczkowska, Anna Leśniak, et al.
European Journal of Medicinal Chemistry (2014) Vol. 92, pp. 64-77
Open Access | Times Cited: 29
μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids
Marino Convertino, Alexander Samoshkin, Josée Gauthier, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2014) Vol. 62, pp. 61-67
Open Access | Times Cited: 27
The importance of translationally evaluating steroid hormone contributions to substance use
Erin E. Maher, Ashley M. Strzelecki, Jessica Weafer, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101059-101059
Open Access | Times Cited: 7
Long‐term opioid treatment and endocrine measures in chronic non‐cancer pain patients
Pernille D. K. Diasso, Dalia Abou‐Kassem, Susanne Dam Nielsen, et al.
European Journal of Pain (2023) Vol. 27, Iss. 8, pp. 940-951
Open Access | Times Cited: 7
Opioids for chronic noncancer pain
Stephen E. Nadeau
Neurology (2015) Vol. 85, Iss. 7, pp. 646-651
Open Access | Times Cited: 22
Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia
Giulia Ponterio, Annalisa Tassone, Giuseppe Sciamanna, et al.
Movement Disorders (2017) Vol. 33, Iss. 2, pp. 310-320
Closed Access | Times Cited: 22
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4′-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands
Yi Zheng, Samuel Obeng, Huiqun Wang, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 2, pp. 561-574
Open Access | Times Cited: 22
Dual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics
Cecilia Betti, Joanna Starnowska-Sokół, Joanna Mika, et al.
ACS Medicinal Chemistry Letters (2015) Vol. 6, Iss. 12, pp. 1209-1214
Open Access | Times Cited: 20
Nalbuphine and butorphanol reverse opioid-induced respiratory depression but increase arousal in etorphine-immobilized goats (Capra hircus)
Anna Haw, Leith C. R. Meyer, Andrea Fuller
Veterinary Anaesthesia and Analgesia (2016) Vol. 43, Iss. 5, pp. 539-548
Closed Access | Times Cited: 17
Design, Synthesis, and Biological Evaluation of NAP Isosteres: A Switch from Peripheral to Central Nervous System Acting Mu-Opioid Receptor Antagonists
Piyusha P. Pagare, Mengchu Li, Yi Zheng, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 5095-5112
Open Access | Times Cited: 10
Cancer Pain Management: Opioid Analgesics, Part 2
Rita Wickham
Journal of the Advanced Practitioner in Oncology (2017) Vol. 8, Iss. 6
Open Access | Times Cited: 18
Personalized Oxycodone Dosing: Using Pharmacogenetic Testing and Clinical Pharmacokinetics to Reduce Toxicity Risk and Increase Effectiveness
Jeffrey Fudin, Timothy Atkinson
Pain Medicine (2014) Vol. 15, Iss. 5, pp. 723-725
Closed Access | Times Cited: 17
Nociception and Pain
Carolyn M. McKune, Joanna C. Murrell, Andrea M. Nolan, et al.
(2015), pp. 584-623
Closed Access | Times Cited: 17
Dynamic Measurement of Extracellular Opioid Activity: Status Quo, Challenges, and Significance in Rewarded Behaviors
Niall Murphy
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 1, pp. 94-107
Closed Access | Times Cited: 16
Effects of fentanyl administration on locomotor response in horses with the G57C μ-opioid receptor polymorphism
Lois A. Wetmore, Peter J. Pascoe, Yael Shilo‐Benjamini, et al.
American Journal of Veterinary Research (2016) Vol. 77, Iss. 8, pp. 828-832
Closed Access | Times Cited: 16
Preliminary Findings of Structure and Expression of Opioid Receptor Genes in a Peregrine Falcon (Falco peregrinus), a Snowy Owl (Bubo scandiacus), and a Blue-fronted Amazon Parrot (Amazona aestiva)
Alexis Duhamelle, Diana L. Raiwet, Isabelle Langlois, et al.
Journal of Avian Medicine and Surgery (2018) Vol. 32, Iss. 3, pp. 173-184
Closed Access | Times Cited: 16
The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
Yuqin Yu, Dapeng Li, Ji’an Duan, et al.
Bioscience Reports (2020) Vol. 40, Iss. 2
Open Access | Times Cited: 15
Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge
Azzurra Stefanucci, Ettore Novellino, Sako Mirzaie, et al.
ACS Medicinal Chemistry Letters (2017) Vol. 8, Iss. 4, pp. 449-454
Open Access | Times Cited: 15
Application of Bivalent Bioisostere Concept on Design and Discovery of Potent Opioid Receptor Modulators
Hongguang Ma, Samuel Obeng, Huiqun Wang, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 24, pp. 11399-11415
Closed Access | Times Cited: 15
Morphine produces potent antinociception, sedation, and hypothermia in humanized mice expressing human mu-opioid receptor splice variants
Yihan Huang, Yu‐Wei Wu, Jian‐Ying Chuang, et al.
Pain (2020) Vol. 161, Iss. 6, pp. 1177-1190
Closed Access | Times Cited: 13
Comparative analysis of the effects of opioids in angiogenesis
Tao Feng, Si Zeng, Jie Ding, et al.
BMC Anesthesiology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Pain and Pain Management in Palliative Care
Abigail E. Franklin, Melanie Lovell
Springer eBooks (2024), pp. 1-27
Closed Access | Times Cited: 1
Splice variation of the mu-opioid receptor and its effect on the action of opioids
Sophy Gretton, Joanne Droney
British Journal of Pain (2014) Vol. 8, Iss. 4, pp. 133-138
Open Access | Times Cited: 13

Scroll to top